Breaking the barrier: from biosynthetic inhibition to multidimensional modulation of the mycobacterial cell wall in tuberculosis therapy
Pan Li, Yanmei Liao, Lingli Zhu, Min Zhang, Yuhan Wang, Li Liao, Tao Wu, Xueliang Chen, Yingyong Xia, Xue Han · 2026
Read Breaking the barrier: from biosynthetic inhibition to multidimensional modulation of the mycobacterial cell wall in tuberculosis therapy by Pan Li, Yanmei Liao, Lingli Zhu, Min Zhang, Yuhan Wang, Li Liao, Tao Wu, Xueliang Chen, Yingyong Xia, Xue Han (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311081.txt.
Description
Pan Li and colleagues review new ways to attack the tuberculosis cell wall in a 2026 paper. Tuberculosis still kills over a million people a year, and drug resistant strains blunt old cures. The germ wall, built from linked sugars, wax acids, and protein mesh, has long been a proven drug target.
Classic drugs block wall building enzymes, but fresh plans go wider. Options disrupt wall strength, starve energy, jam transport of wall parts, enlist host defenses, and use nano carriers for delivery. Joining fronts may yield shorter, stronger cures that resist evasion. Most new paths still await human proof.
Catalog record
| CREATOR | Pan Li, Yanmei Liao, Lingli Zhu, Min Zhang, Yuhan Wang, Li Liao, Tao Wu, Xueliang Chen, Yingyong Xia, Xue Han |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 75444 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |